Literature DB >> 6277657

Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide.

R J Barrett, M F Lokhandwala.   

Abstract

The effect of pergolide, a dopaminergic ergoline, on cardiac sympathetic neurotransmission was examined in pentobarbital-anesthetized dogs. Positive chronotropic responses to right postganglionic cardioaccelerator nerve stimulation were significantly reduced following infusion of pergolide, 1.25 microgram/kg per min for 10 min, whereas positive chronotropic responses to exogenous norepinephrine were unchanged. Pretreatment with sulpiride but not with yohimbine completely antagonized the inhibitory effect of pergolide. These results demonstrate that pergolide inhibits sympathetic neurotransmission to the heart by a specific activation of presynaptic dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277657     DOI: 10.1016/0014-2999(82)90541-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  In vivo and in vitro dopaminergic effects of three ergoline fragments.

Authors:  J C Koons; J P Long; J G Cannon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

Review 2.  Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease.

Authors:  H D Langtry; S P Clissold
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

3.  Involvement of central dopamine receptors in the hypotensive action of pergolide.

Authors:  A L Jadhav; R N Willett; H N Sapru; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

4.  Presynaptic effects of dopexamine hydrochloride in the canine kidney.

Authors:  A S Bass
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.